Industries > Pharma > The Molecular Diagnostics (MDx) Market Forecast 2017-2027

The Molecular Diagnostics (MDx) Market Forecast 2017-2027

Infectious Disease Testing, Oncology Testing, Blood Screening, Genetic Testing, Tissue Typing

PUBLISHED: 08 August 2017
PAGES: 206
PRODUCT CODE: PHA0222

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

The molecular diagnostics (MDx) market was worth $6.13bn in 2016 and is estimated to grow at a CAGR of 12.5% from 2017-2021. The fastest growing segment of the molecular diagnostics market over the forecast period 2017-2027 will be the oncology testing segment. The segment was worth $1.08bn in 2016 and represented 17.6% of the molecular diagnostics market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 206-page report you will receive 135 charts – all unavailable elsewhere.

The 206-page report provides clear detailed insight into the molecular diagnostics (MDx) market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

World IVD market forecasts from 2017-2027

Molecular diagnostics (MDx) market forecasts from 2017-2027

The Molecular Diagnostics (MDx) Market Forecast 2017-2027

Revenue and growth forecasts to 2027 for the leading submarkets:
• Infectious Disease Testing
• Oncology Testing
• Blood Screening
• Genetic Testing
• Tissue Typing

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– US
– Europe:
• Germany
• UK
• Spain
• Italy
• France
• Rest of Europe
– Japan
– China
– Brazil
– Russia
– India
– South Korea
– Mexico
– RoW

• This report discusses the leading companies in the molecular diagnostics (MDx) market:
• Roche Diagnostics
• Qiagen
• Hologic
• Becton, Dickinson & Company
• bioMérieux
• Agilent Technologies

A company profile gives you the following information where available:
• Discussion of a company’s activities and outlook
• Analysis of assays and instruments currently on the market as well as pipeline products
• Acquisitions and strategic partnerships

• This report discusses the SWOT analysis as well as porter’s five forces analysis of the molecular diagnostics (MDx) market

Visiongain’s study is intended for anyone requiring commercial analyses for the molecular diagnostics (MDx). You find data, trends and predictions.

Buy our report today The Molecular Diagnostics (MDx) Market Forecast 2017-2027: Infectious Disease Testing, Oncology Testing, Blood Screening, Genetic Testing, Tissue Typing.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for The Molecular Diagnostics (MDx) Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for The Molecular Diagnostics (MDx) Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Stem Cell Technologies and Applications Market Report 2022-2032

The global stem cell technologies and applications market was valued at US$9,247 million in 2021 and is projected to grow at a CAGR of 8.9% during the forecast period 2022-2032.

01 December 2022

READ

Visiongain Publishes Biosimilars and Follow-On Biologics Market Report 2023-2033

The biosimilars and follow-on biologics market is valued at US$19,668.3 million in 2022 and is projected to grow at a CAGR of 31.14% during the forecast period 2023-2033.

01 December 2022

READ

Visiongain Publishes Medical Imaging Market Report 2022-2032

The Medical Imaging market was valued at US$38.6 billion in 2021 and is projected to grow at a CAGR of 5.46% during the forecast period 2022-2032.

30 November 2022

READ

Visiongain Publishes Antibody Drug Conjugates Market Report 2022-2032

The global antibody drug conjugates market was valued at US$3,668 million in 2021 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

28 November 2022

READ